| Year |
Citation |
Score |
| 2012 |
Berch DB, Wagster MV. Future directions in cognitive aging research: Perspectives from the National Institute on Aging New Frontiers in Cognitive Aging. DOI: 10.1093/acprof:oso/9780198525691.003.0017 |
0.325 |
|
| 1993 |
Wagster MV. Changes in cholinergic receptor subtypes in behaviorally-tested, aged monkeys. Neurobiology of Aging. 14: 693-4. PMID 8295691 DOI: 10.1016/0197-4580(93)90075-M |
0.433 |
|
| 1991 |
Price DL, Martin LJ, Sisodia SS, Wagster MV, Koo EH, Walker LC, Koliatsos VE, Cork LC. Aged non-human primates: an animal model of age-associated neurodegenerative disease. Brain Pathology (Zurich, Switzerland). 1: 287-96. PMID 1688300 DOI: 10.1111/J.1750-3639.1991.Tb00672.X |
0.484 |
|
| 1990 |
Price DL, Koo EH, Wagster MV, Walker LC, Wenk GL, Applegate MD, Kitt CA, Cork LC. Behavioral, cellular, and molecular biological studies of aged nonhuman primates. Advances in Neurology. 51: 83-9. PMID 2403719 |
0.452 |
|
| 1990 |
Wagster MV, Whitehouse PJ, Walker LC, Kellar KJ, Price DL. Laminar organization and age-related loss of cholinergic receptors in temporal neocortex of rhesus monkey. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 2879-85. PMID 2398366 DOI: 10.1523/Jneurosci.10-09-02879.1990 |
0.4 |
|
| 1988 |
Walker LC, Kitt CA, Struble RG, Wagster MV, Price DL, Cork LC. The neural basis of memory decline in aged monkeys. Neurobiology of Aging. 9: 657-66. PMID 3145465 DOI: 10.1016/S0197-4580(88)80130-1 |
0.523 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1990 |
Filloux F, Wagster MV, Folstein S, Price DL, Hedreen JC, Dawson TM, Wamsley JK. Nigral dopamine type-1 receptors are reduced in Huntington's disease: a postmortem autoradiographic study using [3H]SCH 23390 and correlation with [3H]forskolin binding. Experimental Neurology. 110: 219-27. PMID 2146140 DOI: 10.1016/0014-4886(90)90033-O |
0.228 |
|
| 1994 |
Wagster MV, Hedreen JC, Peyser CE, Folstein SE, Ross CA. Selective loss of [3H]kainic acid and [3H]AMPA binding in layer VI of frontal cortex in Huntington's disease. Experimental Neurology. 127: 70-5. PMID 7515353 DOI: 10.1006/Exnr.1994.1081 |
0.226 |
|
| 1988 |
Whitehouse PJ, Martino AM, Wagster MV, Price DL, Mayeux R, Atack JR, Kellar KJ. Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology. 38: 720-3. PMID 3362368 DOI: 10.1212/Wnl.38.5.720 |
0.217 |
|
| 2007 |
Albert MS, Brown DR, Buchner D, Laditka J, Launer LJ, Scherr P, Thies W, Wagster MV. The healthy brain and our aging population: translating science to public health practice. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: S3-5. PMID 19595971 DOI: 10.1016/J.Jalz.2007.01.016 |
0.215 |
|
| 2009 |
Wagster MV. Cognitive aging research: an exciting time for a maturing field : a postscript to the special issue of neuropsychology review. Neuropsychology Review. 19: 523-5. PMID 19943133 DOI: 10.1007/s11065-009-9121-2 |
0.209 |
|
| 1989 |
Atack JR, Wenk GL, Wagster MV, Kellar KJ, Whitehouse PJ, Rapoport SI. Bilateral changes in neocortical [3H]pirenzepine and [3H]oxotremorine-M binding following unilateral lesions of the rat nucleus basalis magnocellularis: an autoradiographic study. Brain Research. 483: 367-72. PMID 2706526 DOI: 10.1016/0006-8993(89)90182-0 |
0.199 |
|
| 1986 |
Brown SG, Wagster MV. Socialization processes in a female lowland gorilla Zoo Biology. 5: 269-279. DOI: 10.1002/Zoo.1430050305 |
0.181 |
|
| 2011 |
Silverberg NB, Ryan LM, Carrillo MC, Sperling R, Petersen RC, Posner HB, Snyder PJ, Hilsabeck R, Gallagher M, Raber J, Rizzo A, Possin K, King J, Kaye J, Ott BR, ... ... Wagster MV, et al. Assessment of cognition in early dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: e60-e76. PMID 23559893 DOI: 10.1016/J.Jalz.2011.05.001 |
0.179 |
|
| 1993 |
Li SH, Schilling G, Young WS, Li XJ, Margolis RL, Stine OC, Wagster MV, Abbott MH, Franz ML, Ranen NG. Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron. 11: 985-93. PMID 8240819 DOI: 10.1016/0896-6273(93)90127-D |
0.17 |
|
| 2007 |
Elias JW, Wagster MV. Developing context and background underlying cognitive intervention/training studies in older populations. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 62: 5-10. PMID 17565160 DOI: 10.1093/geronb/62.special_issue_1.5 |
0.157 |
|
| 1998 |
Aylward EH, Anderson NB, Bylsma FW, Wagster MV, Barta PE, Sherr M, Feeney J, Davis A, Rosenblatt A, Pearlson GD, Ross CA. Frontal lobe volume in patients with Huntington's disease. Neurology. 50: 252-8. PMID 9443488 DOI: 10.1212/Wnl.50.1.252 |
0.151 |
|
| 2011 |
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, ... ... Wagster MV, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 280-92. PMID 21514248 DOI: 10.1016/J.Jalz.2011.03.003 |
0.149 |
|
| 2013 |
Gershon RC, Wagster MV, Hendrie HC, Fox NA, Cook KF, Nowinski CJ. NIH toolbox for assessment of neurological and behavioral function. Neurology. 80: S2-6. PMID 23479538 DOI: 10.1212/WNL.0b013e3182872e5f |
0.145 |
|
| 2008 |
Magassi S, Tulsky D, Victorson D, Gershon R, Nowinski C, Wagster M. Article 7: Filling the National Institutes of Health's Toolbox: Defining Priorities and Selecting Measures for a Uniform Assessment Battery of Neurologic and Behavioral Function Archives of Physical Medicine and Rehabilitation. 89: e2-e3. DOI: 10.1016/J.Apmr.2008.08.015 |
0.135 |
|
| 1997 |
Becher MW, Rubinsztein DC, Leggo J, Wagster MV, Stine OC, Ranen NG, Franz ML, Abbott MH, Sherr M, MacMillan JC, Barron L, Porteous M, Harper PS, Ross CA. Dentatorubral and pallidoluysian atrophy (DRPLA). Clinical and neuropathological findings in genetically confirmed North American and European pedigrees. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 519-30. PMID 9251070 DOI: 10.1002/Mds.870120408 |
0.126 |
|
| 1995 |
Sharp AH, Loev SJ, Schilling G, Li SH, Li XJ, Bao J, Wagster MV, Kotzuk JA, Steiner JP, Lo A. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron. 14: 1065-74. PMID 7748554 DOI: 10.1016/0896-6273(95)90345-3 |
0.126 |
|
| 2012 |
Wagster MV, King JW, Resnick SM, Rapp PR. The 87%. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 67: 739-40. PMID 22773154 DOI: 10.1093/gerona/gls140 |
0.12 |
|
| 1995 |
Schilling G, Sharp AH, Loev SJ, Wagster MV, Li SH, Stine OC, Ross CA. Expression of the Huntington's disease (IT15) protein product in HD patients. Human Molecular Genetics. 4: 1365-71. PMID 7581375 DOI: 10.1093/Hmg/4.8.1365 |
0.114 |
|
| 1995 |
Stine OC, Li SH, Pleasant N, Wagster MV, Hedreen JC, Ross CA. Expression of the mutant allele of IT-15 (the HD gene) in striatum and cortex of Huntington's disease patients. Human Molecular Genetics. 4: 15-8. PMID 7711729 DOI: 10.1093/Hmg/4.1.15 |
0.113 |
|
| 2006 |
Hendrie HC, Albert MS, Butters MA, Gao S, Knopman DS, Launer LJ, Yaffe K, Cuthbert BN, Edwards E, Wagster MV. The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 12-32. PMID 19595852 DOI: 10.1016/J.Jalz.2005.11.004 |
0.105 |
|
| 2002 |
Edwards E, Kitt C, Oliver E, Finkelstein J, Wagster M, McDonald WM. Depression and Parkinson's disease: A new look at an old problem Depression and Anxiety. 16: 39-48. PMID 12203670 DOI: 10.1002/da.10057 |
0.1 |
|
| 1996 |
Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA, Dawson VL, Dawson TM. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proceedings of the National Academy of Sciences of the United States of America. 93: 5037-42. PMID 8643525 DOI: 10.1073/Pnas.93.10.5037 |
0.095 |
|
| 2019 |
Weintraub S, Wagster M, King J, Peipert D, Nowinski C, Gershon R. P3-112: NIH TOOLBOX USE IN THE ASSESSMENT OF MILD COGNITIVE IMPAIRMENT AND DEMENTIA DUE TO ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P973-P973. DOI: 10.1016/J.Jalz.2019.06.3140 |
0.093 |
|
| 1996 |
Margolis RL, Li SH, Young WS, Wagster MV, Stine OC, Kidwai AS, Ashworth RG, Ross CA. DRPLA gene (atrophin-1) sequence and mRNA expression in human brain. Brain Research. Molecular Brain Research. 36: 219-26. PMID 8965642 DOI: 10.1016/0169-328X(95)00241-J |
0.09 |
|
| 2007 |
Elias JW, Wagster MV. Developing Context and Background Underlying Cognitive Intervention/Training Studies in Older Populations. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 62: 5-10. PMID 28158638 DOI: 10.1093/geronb/62.special_issue_1.5 |
0.088 |
|
| 2007 |
Morrison-Bogorad M, Cahan V, Wagster MV. Brain health interventions: the need for further research. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: S80-5. PMID 19595981 DOI: 10.1016/j.jalz.2007.01.015 |
0.072 |
|
| 1998 |
Rosenblatt A, Ranen NG, Rubinsztein DC, Stine OC, Margolis RL, Wagster MV, Becher MW, Rosser AE, Leggo J, Hodges JR, ffrench-Constant CK, Sherr M, Franz ML, Abbott MH, Ross CA. Patients with features similar to Huntington's disease, without CAG expansion in huntingtin. Neurology. 51: 215-20. PMID 9674805 DOI: 10.1212/Wnl.51.1.215 |
0.068 |
|
| 2019 |
Wagster MV, King JW. The expectation breakers. Neurobiology of Aging. 83: 122-123. PMID 31732014 DOI: 10.1016/j.neurobiolaging.2019.04.015 |
0.064 |
|
| 1997 |
Becher MW, Kolzuk JA, Wagster MV, Rosenblatt A, Kitt CA, Price DL, Ross CA. AMYLOID DEPOSITS AND NEURITIC PLAQUES IN HUNTINGTONʼS DISEASE Journal of Neuropathology and Experimental Neurology. 56: 612. DOI: 10.1097/00005072-199705000-00177 |
0.063 |
|
| 1996 |
Becher MW, Wagster MV, Stine OC, Ranen NG, Ross CA. DENTATO-RUBRAL AND PALLIDO-LUYSIAN ATROPHY (DRPLA) Journal of Neuropathology and Experimental Neurology. 55: 637. DOI: 10.1097/00005072-199605000-00140 |
0.06 |
|
| 2016 |
Lavretsky H, Wagster MV, Niederehe G, Evans J. Senior Investigator Workshop The American Journal of Geriatric Psychiatry. 24: S32-S33. DOI: 10.1016/j.jagp.2016.01.047 |
0.04 |
|
| 2016 |
Smith AW, Mitchell SA, K De Aguiar C, Moy C, Riley WT, Wagster MV, M Werner E. News from the NIH: Person-centered outcomes measurement: NIH-supported measurement systems to evaluate self-assessed health, functional performance, and symptomatic toxicity. Translational Behavioral Medicine. 6: 470-4. PMID 27528535 DOI: 10.1007/s13142-015-0345-9 |
0.037 |
|
| 2010 |
Gershon RC, Cella D, Fox NA, Havlik RJ, Hendrie HC, Wagster MV. Assessment of neurological and behavioural function: the NIH Toolbox. The Lancet. Neurology. 9: 138-9. PMID 20129161 DOI: 10.1016/S1474-4422(09)70335-7 |
0.032 |
|
| 2022 |
Wagster MV, King JW. Lost - and Found - in Translation. Neurobiology of Aging. PMID 36641370 DOI: 10.1016/j.neurobiolaging.2022.12.008 |
0.017 |
|
| 1998 |
Cheng DS, Rodriguez RM, Rogers J, Wagster M, Starnes DL, Light RW. Comparison of pleural fluid pH values obtained using blood gas machine, pH meter, and pH indicator strip. Chest. 114: 1368-72. PMID 9824016 DOI: 10.1378/CHEST.114.5.1368 |
0.014 |
|
| 2014 |
Lavretsky H, Wagster MV, Evans JD, Niederehe G. Senior Investigator Workshop on the New NIH Policies for Research Funding and Program Opportunities The American Journal of Geriatric Psychiatry. 22: S30. DOI: 10.1016/j.jagp.2013.12.043 |
0.012 |
|
| Hide low-probability matches. |